Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide

Antonio Di Martino, Alena Pavelkova, Sandra Maciulyte, Saulute Budriene, Vladimir Sedlarik

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Polysaccharide-based nanocomplexes, intended for simultaneous encapsulation and controlled release of 5-Fluorouracil (5-FU) and Temozolomide (TMZ) were developed via the complexation method using chitosan, alginic and polygalacturonic acid. Investigation focused on the influence of polysaccharides on the properties of the system and amelioration of the stability of the drugs, in particular TMZ. The dimensions of particles and their ζ-potential were found to range between 100 and 200 nm and − 25 to + 40 mV, respectively. Encapsulation efficiency varied from 16% to over 70%, depending on the given system. The influence of pH on the release and co-release of TMZ and 5-FU was evaluated under different pH conditions. The stability of the loaded drug, in particular TMZ, after release was evaluated and confirmed by LC–MS analysis. Results suggested that the amount of loaded drug(s) and the release rate is connected with the weight ratio of polysaccharides and the pH of the media. One-way ANOVA analysis on the obtained data revealed no interference between the drugs during the encapsulation and release process, and in particular no hydrolysis of TMZ occurred suggesting that CS-ALG and CS-PGA would represent interesting carriers for multi-drug controlled release and drugs protection.

Original languageEnglish
Pages (from-to)276-286
Number of pages11
JournalEuropean Journal of Pharmaceutical Sciences
Volume92
DOIs
Publication statusPublished - 20 Sep 2016
Externally publishedYes

Fingerprint

temozolomide
Fluorouracil
Polysaccharides
Drug Stability
Prostaglandins A
Chitosan
Pharmaceutical Preparations
Analysis of Variance
Hydrolysis
Weights and Measures

Keywords

  • Alginic acid
  • Chitosan
  • Drug delivery
  • Polyelectrolytes
  • Polygalacturonic acid

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide. / Di Martino, Antonio; Pavelkova, Alena; Maciulyte, Sandra; Budriene, Saulute; Sedlarik, Vladimir.

In: European Journal of Pharmaceutical Sciences, Vol. 92, 20.09.2016, p. 276-286.

Research output: Contribution to journalArticle

Di Martino, Antonio ; Pavelkova, Alena ; Maciulyte, Sandra ; Budriene, Saulute ; Sedlarik, Vladimir. / Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide. In: European Journal of Pharmaceutical Sciences. 2016 ; Vol. 92. pp. 276-286.
@article{f5ac8648265d47f997dd6582556734d3,
title = "Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide",
abstract = "Polysaccharide-based nanocomplexes, intended for simultaneous encapsulation and controlled release of 5-Fluorouracil (5-FU) and Temozolomide (TMZ) were developed via the complexation method using chitosan, alginic and polygalacturonic acid. Investigation focused on the influence of polysaccharides on the properties of the system and amelioration of the stability of the drugs, in particular TMZ. The dimensions of particles and their ζ-potential were found to range between 100 and 200 nm and − 25 to + 40 mV, respectively. Encapsulation efficiency varied from 16{\%} to over 70{\%}, depending on the given system. The influence of pH on the release and co-release of TMZ and 5-FU was evaluated under different pH conditions. The stability of the loaded drug, in particular TMZ, after release was evaluated and confirmed by LC–MS analysis. Results suggested that the amount of loaded drug(s) and the release rate is connected with the weight ratio of polysaccharides and the pH of the media. One-way ANOVA analysis on the obtained data revealed no interference between the drugs during the encapsulation and release process, and in particular no hydrolysis of TMZ occurred suggesting that CS-ALG and CS-PGA would represent interesting carriers for multi-drug controlled release and drugs protection.",
keywords = "Alginic acid, Chitosan, Drug delivery, Polyelectrolytes, Polygalacturonic acid",
author = "{Di Martino}, Antonio and Alena Pavelkova and Sandra Maciulyte and Saulute Budriene and Vladimir Sedlarik",
year = "2016",
month = "9",
day = "20",
doi = "10.1016/j.ejps.2016.05.001",
language = "English",
volume = "92",
pages = "276--286",
journal = "European Journal of Pharmaceutical Sciences",
issn = "0928-0987",
publisher = "Elsevier",

}

TY - JOUR

T1 - Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide

AU - Di Martino, Antonio

AU - Pavelkova, Alena

AU - Maciulyte, Sandra

AU - Budriene, Saulute

AU - Sedlarik, Vladimir

PY - 2016/9/20

Y1 - 2016/9/20

N2 - Polysaccharide-based nanocomplexes, intended for simultaneous encapsulation and controlled release of 5-Fluorouracil (5-FU) and Temozolomide (TMZ) were developed via the complexation method using chitosan, alginic and polygalacturonic acid. Investigation focused on the influence of polysaccharides on the properties of the system and amelioration of the stability of the drugs, in particular TMZ. The dimensions of particles and their ζ-potential were found to range between 100 and 200 nm and − 25 to + 40 mV, respectively. Encapsulation efficiency varied from 16% to over 70%, depending on the given system. The influence of pH on the release and co-release of TMZ and 5-FU was evaluated under different pH conditions. The stability of the loaded drug, in particular TMZ, after release was evaluated and confirmed by LC–MS analysis. Results suggested that the amount of loaded drug(s) and the release rate is connected with the weight ratio of polysaccharides and the pH of the media. One-way ANOVA analysis on the obtained data revealed no interference between the drugs during the encapsulation and release process, and in particular no hydrolysis of TMZ occurred suggesting that CS-ALG and CS-PGA would represent interesting carriers for multi-drug controlled release and drugs protection.

AB - Polysaccharide-based nanocomplexes, intended for simultaneous encapsulation and controlled release of 5-Fluorouracil (5-FU) and Temozolomide (TMZ) were developed via the complexation method using chitosan, alginic and polygalacturonic acid. Investigation focused on the influence of polysaccharides on the properties of the system and amelioration of the stability of the drugs, in particular TMZ. The dimensions of particles and their ζ-potential were found to range between 100 and 200 nm and − 25 to + 40 mV, respectively. Encapsulation efficiency varied from 16% to over 70%, depending on the given system. The influence of pH on the release and co-release of TMZ and 5-FU was evaluated under different pH conditions. The stability of the loaded drug, in particular TMZ, after release was evaluated and confirmed by LC–MS analysis. Results suggested that the amount of loaded drug(s) and the release rate is connected with the weight ratio of polysaccharides and the pH of the media. One-way ANOVA analysis on the obtained data revealed no interference between the drugs during the encapsulation and release process, and in particular no hydrolysis of TMZ occurred suggesting that CS-ALG and CS-PGA would represent interesting carriers for multi-drug controlled release and drugs protection.

KW - Alginic acid

KW - Chitosan

KW - Drug delivery

KW - Polyelectrolytes

KW - Polygalacturonic acid

UR - http://www.scopus.com/inward/record.url?scp=84973099693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973099693&partnerID=8YFLogxK

U2 - 10.1016/j.ejps.2016.05.001

DO - 10.1016/j.ejps.2016.05.001

M3 - Article

C2 - 27154260

AN - SCOPUS:84973099693

VL - 92

SP - 276

EP - 286

JO - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

SN - 0928-0987

ER -